Stivarga - regorafenib
Navigation: NDC > Supplier starting with: B > BAYER HEALTHCARE PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 50419-171 |
| Proprietary Name: | Stivarga |
| Suffix: | |
| Non-Proprietary Name: | regorafenib |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 27-09-2012 |
| Category Name: | NDA |
| Application Number: | NDA203085 |
| Labeler: | BAYER HEALTHCARE PHARMACEUTICALS INC. |
| Substance Name: | REGORAFENIB MONOHYDRATE |
| Active Numerator Strength: | 40 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA] |
| DEA Schedule: |